COMMUNIQUÉS West-GlobeNewswire

Copeland Biosciences Corp. Secures Exclusive Canadian Distribution Rights for CareWear® Wearable Light Therapeutics Systems
29/08/2019
TORONTO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Copeland Biosciences Corp , an orthopedic treatment company that provides remedies to relieve inflammatory pain with proprietary pharmaceutical and cannabis-based topical [...]
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
29/08/2019
- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemphigoid (BP) announced April 2019 Phase I/II clinical study in patients with moderate-to- [...]
TRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare Conference
29/08/2019
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019
29/08/2019
TUSTIN, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Neos Therapeutics to Present at Two Upcoming September Conferences
29/08/2019
DALLAS and FORT WORTH, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and [...]
Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
29/08/2019
NEWTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
29/08/2019
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14 th Monaco Biennale of Oncology 2020 The Award recognizes Patient Entrepreneurs demonstrating [...]
ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
29/08/2019
Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, [...]
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29/08/2019
RALEIGH, N.C., Aug. 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
Editas Medicine to Participate in Upcoming Investor Conferences
29/08/2019
CAMBRIDGE, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following investor conferences in [...]
Mustang Bio to Present at September 2019 Investor Conferences
29/08/2019
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Maple Leaf Green World Inc. Has Retained Aaron Boh as Chief Grower to Spearhead Its One Of The Largest Indoor Cultivation Facility For Hemp Seeds and MJ Clones in Canada
29/08/2019
CALGARY, Alberta, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces the following: Maple Leaf Green World is pleased to announce that [...]
Kaleido Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
29/08/2019
LEXINGTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and [...]
MediPharm Labs Announces Participation at Upcoming Conferences
29/08/2019
TORONTO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]
ChemioCare Strengthens its Proposed Slate of Directors with the Nomination of Multiple Myeloma Expert Dr. Mohamad Hussein
29/08/2019
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the addition of Dr. Mohamad Hussein to the [...]
Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Symposium
29/08/2019
DEVON, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
T2 Biosystems to Present at the Janney Healthcare Conference 2019
29/08/2019
LEXINGTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
TG Therapeutics Announces Data Presentations at the Upcoming 35th Annual Congress of ECTRIMS
29/08/2019
Presentations include Phase 3 ULTIMATE program study design and patient demographic information, and long-term safety data from the Phase 2 trial of ublituximab in MS NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- TG [...]
Kura Oncology to Participate in Two Upcoming Investor Conferences
29/08/2019
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced [...]

Pages